GE HealthCare Technologies Operating Cash Flow decreased by 72.4% to $290.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 16.0%, from $250.00M to $290.00M. Over 4 years (FY 2021 to FY 2025), Operating Cash Flow shows an upward trend with a 5.4% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
An increase indicates strong operational efficiency and cash generation, while a decrease may signal operational challenges or issues with working capital management.
This metric represents the total cash generated or consumed by a company's core business operations during a specific pe...
Standard across all industries; peers in the medical device and diagnostics sector typically maintain high conversion ratios of net income to operating cash flow.
net_cash_from_operating| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $401.75M | $401.75M | $401.75M | $468.00M | -$19.00M | $622.00M | $1.06B | $468.00M | -$67.00M | $650.00M | $1.05B | $419.00M | -$119.00M | $742.00M | $913.00M | $250.00M | $94.00M | $593.00M | $1.05B | $290.00M |
| QoQ Change | — | +0.0% | +0.0% | +16.5% | -104.1% | >999% | +70.9% | -56.0% | -114.3% | >999% | +61.5% | -60.1% | -128.4% | +723.5% | +23.0% | -72.6% | -62.4% | +530.9% | +77.1% | -72.4% |
| YoY Change | — | — | — | — | -104.7% | +54.8% | +164.6% | +0.0% | -252.6% | +4.5% | -1.2% | -10.5% | -77.6% | +14.2% | -13.0% | -40.3% | +179.0% | -20.1% | +15.0% | +16.0% |